An interventional study of Ibuprofen 600 mg and Lorazepam 1 mg in Subfertility and Infertility, sponsored by University of Sao Paulo. Completed. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-08.
Sponsored by University of Sao Paulo · Not applicable, Interventional, and Supportive care
The aim of this study is to evaluate whether Ibuprofen alone or combined with lorazepam reduce the pain associated with endometrial scratching/injury.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 150 is above the median of 120 across 1,698 interventional studies indexed under Infertility.
Browse Infertility studies →University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Oral ibuprofen (600 mg) + lorazepam (1 mg); one hour before endometrial scratching.
Drug: Ibuprofen 600 mg · Drug: Lorazepam 1 mg
Oral ibuprofen (600 mg) + Placebo; one hour before endometrial scratching.
Drug: Ibuprofen 600 mg · Drug: Placebo
Placebo + Placebo; one hour before endometrial scratching.
Drug: Placebo
Maximum pain during procedure
Evaluated by both visual analog scale (10 cm) and numeric verbal scale (0 to 10).
Time frame: 5 minutes
Pain after the procedure
Evaluated by both visual analog scale (10 cm) and numeric verbal scale (0 to 10).
Time frame: 5 minutes
Rejection to a new procedure
Evaluated by a 5-point Likert scale, commenting on this sentence: "I would repeat this procedure if it were indicated". 1 = I fully agree; 2 = I agree; 3 =Neither agree nor disagree; 4 = Disagree; 5 = Strongly Disagree.
Time frame: 5 minutes
No study locations are listed for this record.
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Sao Paulo